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How stem cells generate both differentiating
and self-renewing daughter cells is unclear.
Here, we show that Drosophila larval neuro-
blasts—stem cell-like precursors of the adult
brain—regulate proliferation by segregating
the growth inhibitor Brat and the transcription
factor Prospero into only one daughter cell.
Like Prospero, Brat binds and cosegregates
with the adaptor protein Miranda. In larval neu-
roblasts, both Brat and Prospero are required
to inhibit self-renewal in one of the two daughter
cells. While Prospero regulates cell-cycle gene
transcription, Brat acts as a posttranscriptional
inhibitor of dMyc. In brat or prospero mutants,
both daughter cells grow and behave like neu-
roblasts leading to the formation of larval brain
tumors. Similar defects are seen in lethal giant
larvae (lgl) mutants where Brat and Prospero
are not asymmetric. We have identified a molec-
ular mechanism that may control self-renewal
and prevent tumor formation in other stem cells
as well.
INTRODUCTION
The recent identification of tumor stem cells has chal-
lenged our view of tumorigenesis (Al-Hajj and Clarke,
2004). It is now thought that individual tumor cells vary
considerably in their ability to generate the other cell types
and only very few stem cells exist that can recreate the
whole tumormass. Conventional therapies targeted at de-
stroying rapidly proliferating cells may not always hit these
stem cells, and this could explain why tumors often re-
lapse even after a dramatic reduction of tumor mass
(Michor et al., 2005). Understanding how proliferation
and self-renewal are regulated in stem cells is therefore
an important prerequisite for developing new therapeutic
strategies.CThe development of theDrosophila central nervous sys-
tem (CNS) has been well described during embryogenesis
(Betschinger and Knoblich, 2004) and can serve as a
model for certain aspects of stem cell biology. CNS neu-
rons arise from neuroblasts that divide asymmetrically into
a larger cell that retains neuroblast characteristics and
continues to divide in a stem cell-like fashion and a smaller
so-called ganglion mother cell (GMC) that divides only
once more into two differentiating neurons. During each
neuroblast division, the endocytic protein Numb (Knoblich
et al., 1995), the transcription factor Prospero (Hirata et al.,
1995; Knoblich et al., 1995), and the RNA binding protein
Staufen (Broadus et al., 1998; Schuldt et al., 1998; Shen
et al., 1998) localize asymmetrically to the basal cell cortex
and segregate into the GMC. While Staufen is dispensible
for neuronal specification, Numb was shown to act as a
cell-fate determinant in other tissues (Rhyu et al., 1994),
and Prospero controls GMC-specific genes in some neu-
roblast lineages (Doe et al., 1991; Vaessin et al., 1991).
However, neither numb nor prospero mutants show a
transformation of GMCs into neuroblasts, suggesting
that other determinants exist. Asymmetric segregation of
Staufen and Prospero requires the protein Miranda
(Broadus et al., 1998; Ikeshima-Kataoka et al., 1997; Mat-
suzaki et al., 1998; Schuldt et al., 1998; Shen et al., 1997,
1998). Miranda associates and colocalizes with Prospero
and Staufen and acts as an adaptor that is essential for
their localization to the plasmamembrane and their asym-
metric segregation into only one daughter cell. Asymmet-
ric protein segregation into the GMC requires a conserved
protein complex consisting of Par-3 (Schober et al., 1999;
Wodarz et al., 1999), Par-6 (Petronczki and Knoblich,
2001), and the protein kinase aPKC (Rolls et al., 2003;Wo-
darz et al., 2000). These proteins localize apically before
and during neuroblast division and are essential for deter-
minant localization in neuroblasts. The key substrate for
aPKC is the cytoskeletal protein Lgl (Lethal (2) giant larvae)
(Betschinger et al., 2003). Lgl is required for the cortical lo-
calization of Miranda and its binding partners (Ohshiro
et al., 2000; Peng et al., 2000), but phosphorylation inacti-
vates the protein by inducing an intramolecular associa-
tion (Betschinger et al., 2005). It is thought that Miranda lo-
calizes asymmetrically because aPKC phosphorylationell 124, 1241–1253, March 24, 2006 ª2006 Elsevier Inc. 1241
on one side of the neuroblast restricts Lgl activity—and
consequently cortical recruitment of Miranda—to the op-
posite side.
Drosophila embryonic neuroblasts divide no more than
12 times (Bossing et al., 1996). Since there is no significant
cell growth throughout embryogenesis, they shrink with
each division and their proliferation is limited by their de-
creasing size (Fuse et al., 2003). This is different during lar-
val development where a small number of neuroblasts
gives rise to thousands of neurons in the adult fly brain.
Larval neuroblasts seem to use the same molecular ma-
chinery that regulates asymmetric cell division during em-
bryogenesis (Akong et al., 2002; Ceron et al., 2001; Rolls
et al., 2003). Larval brain development is accompanied
by a dramatic increase in tissue size, suggesting that neu-
roblasts are able to grow between each asymmetric divi-
sion. How cell growth in the nervous system is regulated
is completely unclear. Several mutants have been iden-
tified which lead to overproliferation and formation of en-
larged tumor-like brains (Gateff, 1978). Remarkably, sev-
eral of these mutants affect genes like lgl, which have
been implicated in asymmetric cell division, suggesting
that growth regulation might involve the asymmetric seg-
regation of proliferation control genes. We have identified
the growth regulator Brat as an asymmetrically segregat-
ing determinant that cooperates with the transcription fac-
tor Prospero to establish GMC fate in the embryonic ner-
vous system and controls proliferation in the larval brain.
Like lgl mutants, brat mutants show overgrowth and neo-
plastic transformations in the larval brain. Our data sug-
gest that this is due to a transformation of GMCs into
additional neuroblasts resulting in exponential overprolif-
eration of neural precursor cells. We show that Brat might
be a posttranscriptional regulator of dMyc and thereby
control ribosome biogenesis and protein translation. We
propose that the asymmetric segregation of growth regu-
lators might be a general mechanism by which stem cells
regulate self-renewal and control the balance between
proliferating and differentiating daughter cells.
RESULTS
Brat Is a Binding Partner of Miranda
To identify additional proteins that segregate into theGMC
during neuroblast division, we searched biochemically for
binding partners of Miranda. Miranda acts as an adaptor
that binds to Staufen and Prospero via a C-terminal do-
main (Fuerstenberg et al., 1998; Matsuzaki et al., 1998;
Schuldt et al., 1998; Shen et al., 1998) and is required
for their segregation into the GMC. TAP (tandem affinity
purification)-tagged Miranda deletion constructs (Fig-
ure 1A) were expressed in transgenic flies and isolated
from protein extracts on an IgG column via the protein A
part of the tag. Specific and nonspecific interaction part-
ners were eluted by low pH and analyzed by LC-MS/MS
(see Experimental Procedures). While hundreds of inter-
action partners were identified with each construct, only
four proteins could reproducibly be isolated with the1242 Cell 124, 1241–1253, March 24, 2006 ª2006 Elsevier Inc.C-terminal domain but were never present in any of the
other isolates. Besides Staufen and Prospero, we iden-
tified Brat and CG17593 as novel specific Miranda inter-
action partners. We generated transgenic flies expressing
N-terminally GFP-tagged versions of both proteins. While
GFP-CG17593 is cytoplasmic (Figure 1B), GFP-Brat co-
localizes with Prospero at the basal cell cortex of neuro-
blasts (Figure 1C) and was therefore chosen for further
analysis.
Brat Is a Segregating Cell-Fate Determinant
To test the expression and subcellular localization of Brat,
we raised antibodies against an N-terminal peptide of the
protein. Brat is a uniformly expressed cytoplasmic protein.
In dividing embryonic neuroblasts, Brat colocalizes with
Miranda throughout mitosis: it accumulates at the apical
cell cortex in prophase (Figure 1D), forms a basal crescent
in metaphase (Figure 1E), and segregates into the GMC. It
is cortical in telophase (Figure 1F) but becomes cytoplas-
mic in interphase after Miranda is degraded (Figure 1F,
open arrowhead). In prospero mutants, Brat localization
is unaffected (Figure 1J) but in miranda mutant neuro-
blasts, Brat is cytoplasmic throughout mitosis (Figure 1K).
Conversely, neither Prospero nor Miranda localization is
affected in embryos lacking both maternal and zygotic
brat function (data not shown). Asymmetric segregation
of Brat is also observed in dividing sensory organ precur-
sor (SOP) cells where Miranda is expressed but without
a described function (Figures 1G–1I). Thus, Brat is the third
protein besides Prospero and Staufen that uses Miranda
as an adaptor to segregate into one of the two daughter
cells during asymmetric cell division.
To characterize Brat function, we studied nervous sys-
tem development in brat mutant embryos. We chose to
analyze a subset of neurons that can be identified by
even-skipped (Eve) expression and that has been studied
in mutants affecting asymmetric cell division before (Doe
et al., 1991; Ikeshima-Kataoka et al., 1997). In wild-type
embryos, the EL (Figure 2A, arrowhead), RP2 (Figure 2A,
open arrowhead), aCC/pCC, and U/CQ neurons express
Eve. In prospero mutants, most of the Eve-expressing
RP2, aCC/pCC, and U/CQ neurons are missing but the
EL cluster is largely unaffected (Doe et al., 1991 and Fig-
ure 2C). Zygotic brat mutant embryos have no obvious
CNS phenotype (Figure 2B and data not shown), but in
embryos lacking both maternal and zygotic brat function,
RP2 neurons are frequently missing (Figure 2E, open ar-
rowhead). This analysis is however complicated by the
strong morphological defects that are observed in em-
bryos lacking maternal and zygotic brat due to a role in
translation of the gap gene hunchback (Sonoda andWhar-
ton, 2001). Since overexpression of GFP-Brat causes an
increase in the numbers of RP2 neurons (marked by the
expression of Eve and Zfh-1 in Figure 2F), we believe
that Brat acts as a cell-fate determinant in the embryonic
CNS. This is further supported by a strong genetic in-
teraction between brat and prospero: In embryos lack-
ing zygotic prospero and zygotic brat function, most
Figure 1. Identification of Miranda Binding Proteins
(A) Schematic representation of Miranda deletion constructs used for the identification of interacting protein (green: asymmetry domain; red: cargo
domain).
(B and C) GFP-Brat (C), but not GFP-CG17593 (B) colocalizes asymmetrically with Prospero in metaphase embryonic neuroblasts.
(D–I) Brat localizes to the apical cell cortex of embryonic neuroblasts in prophase (D, arrowhead), localizes basally in metaphase (E, arrowhead), seg-
regates into the basal GMC in telophase (F, arrowhead), and is enriched in the cytoplasm of GMCs (F, open arrowhead). In metaphase SOP cells, Brat
is localized to the anterior cell cortex (G), segregates asymmetrically during telophase (H), and is enriched in the anterior pIIb daughter cell after
cytokinesis (I).
(J and K) Brat localizes asymmetrically in pros17 (J), but not miraL44 (K) mutant neuroblasts. Scale bars are 10 mm.Eve-expressing neurons are missing, leading to dramatic
defects and a severe reduction of axonal marker staining
in the embryonic CNS (Figure 2D). Thus, brat and prospero
are partially redundant in specifying cell fates in embryonic
neurons.
Brat Controls Proliferation and GMC Fate
in the Larval CNS
Brat is amember of a family of evolutionarily conserved tu-
mor suppressor proteins (Arama et al., 2000). Besides
Brat, this family contains the Drosophila proteins Dappled
and Mei-P26 and the mouse proteins TRIM2, TRIM3, and
TRIM32. While dappledmutants develop tumors in the fat
body (Rodriguez et al., 1996) and mei-P26 mutants have
ovarian tumors (Page et al., 2000), brat mutants showCbrain overgrowth (Gateff, 1978). We therefore character-
ized brat mutant larval brains by staining with neuroblast
and cell-cycle markers. Drosophila larval neuroblasts
can be identified by staining for Miranda (Mira) and by
the expression of membrane bound CD8-GFP in neuro-
blasts and all their progeny from the Gal4 line 1407 in-
serted in the inscuteable promotor. Neuroblasts are pres-
ent in the ventral nerve cord, the optic lobes, and in the
medial areas of the two brain lobes where they are called
central brain (CB) neuroblasts (Figure 3A). In the anterior
half of the brain (Figure 3B), CB neuroblasts seem to be
continuous with neuroblasts in the ventral nerve cord
and generate less than a hundred neurons with some lin-
eages projecting into the ventral ganglion. On the poste-
rior side (Figure 3C), CB neuroblasts can generate severalell 124, 1241–1253, March 24, 2006 ª2006 Elsevier Inc. 1243
Figure 2. Brat Acts as a Cell-Fate Determinant in the Embryonic Central Nervous System
Merged confocal z stacks of stage 15 embryos. (A–D) Eve (arrowheads mark EL neuron cluster, open arrowheads RP2 neurons) and BP102 expres-
sion is normal in brat150 embryos (B). Although CNS morphology is severly impaired in pros17 mutants, the EL neuron cluster is unaffected (C). In
pros17,brat150 embryos, the EL neurons are mostly missing and axon formation is greatly alleviated (D). (E) brat150 maternal/zygotic mutant embryos
show loss of RP2 neurons (open arrowhead), while overexpression of GFP-Brat using maternalGal4 increases the number of Eve- and Zfh1-express-
ing RP2 neurons (open arrowhead) from two per segment to three (29.7% of n = 164 segments) or four (7.1%). Scale bars are 20 mm.hundred neurons which project ipsi- and contralaterally
within the brain.
Like in embryonic neuroblasts, Brat localizes asymmet-
rically and segregates into the GMC during larval neuro-
blast division (see Figures 5A and 5U). During early third
instar, the number of Miranda-positive neuroblasts in
brat mutant brains is comparable to wild-type (Figures
3D and 3E). During mid-third instar, however, the number
of CB neuroblasts in the posterior half of the brain is dra-
matically increased (Figures 3F and 3G). By late-third in-
star, BrdU-incorporating neuroblasts overgrow essentially
the whole brain (Figures 3H–3M). We reproducibly detect
a region that is free of Miranda-expressing cells and
seems to correspond to the position of the proliferation
centers of the optic lobes (Figure 3J, arrowhead). Double
staining with Prospero (Pros), a marker for differentiating
cells in the larval CNS, reveals that neuroblast overprolif-
eration is at the expense of GMCs and neurons (Figures
3H–3K). The excess neuroblasts observed in bratmutants
are positive for Cyclin E (CycE) (Figures 3N and 3O) and
Worniu (Wor) (Figures 3P and 3Q).
Individual Neuroblasts Overproliferate in brat
Mutant Brains
The brat mutant phenotype could be due to specification
of more neuroblasts or a defect in the neuroblast lineage.
To distinguish these possibilities, we labeled individual
wild-type or brat mutant neuroblasts using the MARCM
system (Lee and Luo, 1999). This method allows the gen-
eration of individual homozygous mutant neuroblast
clones which express membrane bound CD8-GFP in an
otherwise heterozygous, GFP-negative background. We
focused our analysis on the posterior CB neuroblasts
which seem to be responsible for the overgrowth pheno-1244 Cell 124, 1241–1253, March 24, 2006 ª2006 Elsevier Inctype in brat mutants. Control clones always contain one
largeMiranda (Figure 4A0), Worniu (Figure 4C0 0), and Cyclin
E (Figure 4C0) positive neuroblast and small Prospero-
expressing daughter cells that extend one axon bundle
(Figure 4A0 0, open arrowheads and data not shown). Mi-
randa, Worniu, and Cyclin E expression is downregulated
in the small daughter cells (Figures 4A0, 4C0, and 4C0 0), al-
though some remnants can be found in the most recently
generated GMCs (open arrowheads). In comparison to
wild-type clones (172 cells per clone of n = 14 clones),
brat mutant clones are dramatically enlarged (707 cells
per clone of n = 6 clones) (Figure 4E). Most cells in brat
clones coexpress Miranda, Worniu, and Cyclin E (Figures
4B and 4D), and themitotic index is significantly increased
compared to wild-type clones (0.96 of n = 14 wild-type
clones compared to 3.44 of n = 6 brat clones) (Figure 4E).
Prospero is not expressed and no axons extend from any
of the daughter cells (Figure 4B0 0 and data not shown).
While control clones always have one large (>8 mm) and
many small cells, cell size is more variable in brat mutant
clones and more cells are larger than 8 mm in diameter
(Figure 4F). Thus, in wild-type neuroblasts, the daughter
cell that inherits Brat downregulates Miranda and Worniu,
exits the cell cycle, stops cell growth, and differentiates
into a neuron. In the absence of Brat, however, this cell
expresses neuroblast markers, grows, and continues the
cell cycle leading to exponential proliferation and tumor
formation.
Aberrant Growth Control in Mutants Affecting
Brat Asymmetry
To test whether Brat acts as a segregating cell growth in-
hibitor, we analyzed brain development in mutants affect-
ing the asymmetric localization of Brat. Like Miranda, Brat.
Figure 3. Loss of Brat Leads to Overgrowth of Neuroblasts
(A) Schematic view of the larval central nervous system.
(B andC) Confocal slice of the anterior (B; green slice in A) and posterior (C; red slice in A) region of a 1407-Gal4 larval brain lobe expressing CD8-GFP.
Insets show magnified regions of the anterior (B0 and B0 0) and posterior (C0 and C0 0) brain (neuroblasts marked by arrowheads).
(D–G) Miranda-expressing neuroblasts overgrow in the posterior brain region in brat mutants during mid (G) but not early (E) third instar stages.
(H–M) In contrast to control late third instar larval brains (I and L), BrdU-incorporating (M) and Miranda-expressing neuroblasts (K) overgrow the pos-
terior region in bratmutant brains and invade into the anterior brain cortex (H and J). Neuroblast overgrowth is to the expense of Prospero-expressing
neurons (red in H–K).
(N–Q) Overgrowing cells express Cyclin E (O) and Worniu (Q).
Genotypes are brat150/brat192 (E, G, J, K, M, O, and Q). Scale bars are 50 mm (B–M) and 10 mm (N–Q).localization requires the cytoskeletal protein Lgl (Figures
5A and 5B). lgl was originally identified as a mutation
that leads to neoplastic transformation and overgrowth
of larval tissues (Hadorn, 1938). In lglmutants, a visible in-
crease in brain size can be detected at the end of larval de-
velopment. It has been proposed that this is due to an
overproliferation of larval neuroblasts (Gateff, 1978). In-
deed, while neuroblast number and position are un-
changed in lgl mutants during early third instar larval
stages (data not shown), we detect a significant increase
in the number of posterior CB neuroblasts duringmid-third
instar (Figures 5C and 5D). During late-third instar, the
number of posterior CB neuroblasts is dramatically in-
creased (Figures 5G and 5H) while anterior CB neuro-blasts still appear approximately normal in number and
spacing (Figures 5E and 5F). Overgrowing cells incorpo-
rate BrdU (Figures 5I and 5J) and almost all cells in the
posterior brain express the neuroblast markers Miranda
and Worniu (Figures 5O and 5P) and are positive for the
cell-cycle marker Cyclin E (Figures 5M and 5N). Neuro-
blast overproliferation in lgl mutants is at the expense
of differentiating cells since the number of Prospero-
expressing cells is strongly reduced (Figures 5K and 5L).
Thus, lgl mutants are remarkably similar to brat mutants,
suggesting that Brat needs to segregate into one of the
two daughter cells to act as a growth inhibitor. Consistent
with this, we also detect neuroblast overgrowth upon in-
activation of Lgl by neuroblast-specific overexpressionCell 124, 1241–1253, March 24, 2006 ª2006 Elsevier Inc. 1245
Figure 4. Brat Inhibits Neuroblast Fate, Cell Cycle, and Cell Growth in Daughter Cells
(A–D) CD8-GFP-expressing single-cell neuroblast MARCM clones. In control clones, the neuroblast (arrowhead) and only some recently generated
small daughter cells (open arrowheads) expressMiranda (A0), Cyclin E (C0), andWorniu (C0 0) while all daughter cells show nuclear Prospero (A0 0). In brat
clones, all daughter cells express Miranda (B0), Cyclin E (D0), and Worniu (D0 0 ) but are negative for Prospero (B0 0).
(E) Four days after induction, brat192 clones contain more cells (left) and the percentage of mitotic cells scored by expression of phosphoH3 is
increased (right) as compared to control clones.
(F) brat150 cells grow to neuroblast-like sizes 3 days after clone induction.
Genotypes are hsFlp, C155-Gal4, UAS-CD8-GFP; FRT40A/FRT40A (A and C); hsFlp, C155-Gal4, UAS-CD8-GFP; FRT40A, brat150/FRT40A, brat150
(B); hsFlp, C155-Gal4, UAS-CD8-GFP; FRT40A, brat192/FRT40A, brat192 (D). Scale bars are 10 mm. **: p < 0.05 (Student’s t test); error bars are stan-
dard deviation of the mean.of constitutively active aPKC, a kinase that phosphory-
lates and inactivates Lgl (Figures 5Q–5T). Furthermore,
depletion of Miranda by transgenic RNAi in neuroblasts1246 Cell 124, 1241–1253, March 24, 2006 ª2006 Elsevier Inc.causes an increase in proliferating neuroblasts (Figures
5U–5X and data not shown). However, no brain tumors
were detected in lgl mutant clones. Since asymmetric
Figure 5. Loss of Lgl Leads to Overgrowth of Neuroblasts
(A and B) Brat and Miranda are localized to the cytoplasm of mitotic lgl mutant neuroblasts.
(C–J) Loss of Lgl leads to overgrowth of Miranda-expressing cells in the posterior (H) but not the anterior (F) brain region of late third instar larvae.
Overgrowth becomes already apparent during mid-third instar stages (D).
(I–P) Overgrowing cells incorporate BrdU (J), fail to generate differentiating Prospero-positive daughter cells (L), and express Cyclin E (N) and
Worniu (P).
(Q–T) Overexpression of aPKCDNusing 1407-Gal4 delocalizesMiranda into the cytoplasm ofmitotic neuroblasts (R) and leads to amild overgrowth of
neuroblasts in the posterior brain cortex (T).
(U–X) Expression of Mira RNAi delocalizes Brat into the cytoplasm of mitotic neuroblasts (V) and leads to overgrowth of Cyclin E-positive cells in the
posterior brain region (X).
Genotypes are lgl1/lgl1 (F, H, and L) and lgl1/lgl4 (B, D, J, N, and P). Scale bars are 50 mm (C–J) and 10 mm (A, B, K–X).Miranda localization is unaffected in these clones (data not
shown), we assume that the lack of a clonal lgl phenotype
is due to perdurance of Lgl protein.
Brat Regulates Nucleolar Size in Neuroblasts
How does Brat suppress cell growth in GMCs and neu-
rons? The best studied signaling pathway that controls
growth and proliferation in Drosophila involves the insulin
receptor (InsR), its downstream target PI3K (phosphatidyl-
inositol-3 kinase), and the PI3K inhibitor PTEN (Goberd-Chan et al., 1999; Leevers et al., 1996). Since activation of
this pathway leads to cytoplasmic retention of the tran-
scription factor dFOXO (Puig et al., 2003), we used anti-
dFOXO staining to test the InsR pathway in wild-type
and brat mutant brains. Both in neuroblasts and GMCs,
dFOXO is found mostly in the cytoplasm and its subcellu-
lar localization is unchanged in brat mutant neuroblasts
(Figures 6A and 6B). Furthermore, overexpression of
wild-type or dominant-negative Dp110, the catalytic
subunit of PI3K (Leevers et al., 1996), did not result inell 124, 1241–1253, March 24, 2006 ª2006 Elsevier Inc. 1247
Figure 6. Brat Inhibits dMyc Expression Posttranscriptionally
(A and B) dFOXO localizes to the cytoplasm of neuroblasts (arrowheads) and Prospero-expressing daughter cells (open arrowheads) in control (A) and
brat brains (B).
(C) dMyc is detected in neuroblasts (arrowhead) but not daughter cells (open arrowhead) in control tissue while it is ubiquitously expressed in brat
mutant cells.
(D) Clonal induction of dMyc and lacZ using actinGal4 reveals expression of dMyc in neuroblasts (arrowheads) but not daughter cells (open arrow-
heads).
(E) Overexpressed dMyc is detected in brat mutant cells.
(F and G) Nucleolar size in control (1407-Gal4 expressing CD8-GFP) and brat brains. Neuroblasts are marked by arrowheads and daughter cells by
open arrowheads. Note that the CD8-GFP panel used for cell size measurement is not shown in (F).
(H) Quantification of the ratio between nucleolar and cellular diameter.
Genotypes are brat150/brat192 (B and G); hsFlp, C155-Gal4, UAS-CD8-GFP; FRT40A, brat150/FRT40A, brat150 (C); actinGal4, UAS-dMyc, UAS-
lacZ (D); hsFlp, C155-Gal4, UAS-CD8-GFP; FRT40A, brat150/FRT40A, brat150; UAS-dMyc (E); and 1407-Gal4, UAS-CD8-GFP (F). Scale bars are
10 mm. **: p < 0.05 (Student’s t test); error bars are standard deviation of the mean.neuroblast overgrowth or change the size ratio between
neuroblasts and GMCs significantly (Figure S1). Thus,
the brat mutant phenotype does not seem to be caused
by altered activity of the InsR pathway.
Besides the InsR pathway, the transcription factor
dMyc has been described as an important regulator of
cell-cycle progression and cell growth. In control brains
(Figure 6C and data not shown), dMyc is expressed in
neuroblasts (Figure 6C0, arrowhead) but not in the differen-1248 Cell 124, 1241–1253, March 24, 2006 ª2006 Elsevier Intiating daughter cells (Figure 6C0, open arrowheads). In
brat mutant clones, however, dMyc is found in all cells
(Figure 6C0), suggesting that Brat directly or indirectly in-
hibits dMyc expression. To test whether dMyc is regu-
lated transcriptionally or posttranscriptionally, we over-
expressed dMyc in the larval neuroblast lineage using
the UAS-Gal4 system. We used a line in which the actin
promoter and the Gal4 coding region are separated by
a stop cassette which can be removed by Flp-mediatedc.
recombination. When recombined in a single neuroblast,
this line drives lacZ expression in all daughter cells
(Figure 6D). Overexpressed dMyc protein, however, is de-
tected specifically in the neuroblast (Figure 6D0, arrow-
head), indicating that it is inhibited posttranscriptionally
in the differentiating daughter cells. When overexpressed
in a brat mutant clone, however, dMyc is detected in all
daughter cells (Figure 6E0), indicating that Brat is required
for the posttranscriptional inhibition of dMyc in one of the
two daughter cells of larval neuroblasts.
dMyc regulates cell growth by controlling the synthesis
of ribosomal RNA in the nucleolus, thereby influencing ri-
bosome biogenesis (Grewal et al., 2005). Interestingly,
brat aswell as itsC. elegans homolog ncl-1 regulate nucle-
olar growth (Frank et al., 2002; Frank and Roth, 1998). To
test whether Brat could regulate cell growth by affecting
nucleolar biogenesis in neuroblasts, we analyzed the nu-
cleolus using the marker Fibrillarin. In wild-type neuro-
blasts, the nucleolus is consistently larger than in GMCs
(Figure 6F). In bratmutants, however, all cells have an en-
larged nucleolus (Figure 6G). This is not an indirect conse-
quence of the increase in cell size since the ratio between
nucleolar and cellular diameter is significantly increased
(Figure 6H). We conclude that Brat regulates the size of
the nucleolus in the Drosophila brain, presumably by
downregulating dMyc expression. Since dMyc expression
and nucleolar size have been shown to correlate with ribo-
somal RNA synthesis and cell growth in other tissues
(Frank et al., 2002), it is conceivable that Brat inhibits
growthof theGMCby reducing its rateof protein synthesis.
Prospero Acts as Tumor Suppressor
in the Larval Brain
Our data show a strong genetic interaction between Brat
and Prospero in the embryonic CNS. To test whether
Prospero also acts as a tumor suppressor in the larval
CNS, we analyzed prospero mutant MARCM clones. As
in bratmutant clones, we observe dramatic overprolifera-
tion when such clones are generated in the posterior half
of the brain lobes. In contrast to Brat, however, loss of
Prospero can also generate tumors in the ventral nerve
cord (data not shown). Cells in prospero mutant tumors
are enlarged and express the neuroblast markers Miranda
and Worniu as well as the proliferation marker Cyclin E
(Figures 7A and 7B and data not shown). Surprisingly,
however, these clones downregulate the expression of
Brat (Figure 7B0). Thus, in contrast to embryos where
Brat and Prospero act redundantly to specify GMC fate,
their expression is co-dependent in larval brain neuro-
blasts, and this may explain why mutations in either
gene can induce the formation of neuroblast tumors.
DISCUSSION
How stem cells regulate their proliferation rate and how
they control the balance between self-renewing and differ-
entiating daughter cells is not understood. Our data reveal
a molecular mechanism that controls self-renewal in Dro-sophila larval neuroblasts. We show that the growth regu-
lator Brat segregates asymmetrically during neuroblast di-
vision and inhibits self-renewal in one of the two daughter
cells. Together with the asymmetrically segregating tran-
scription factor Prospero, Brat ensures that this daughter
cell will stop growing, exit the cell cycle, and differentiate
into neurons. In brat or prosperomutants, or in lglmutants,
where Brat and Prospero are not asymmetrically segre-
gated, both daughter cells proliferate leading to the for-
mation of a brain tumor and death of the animal. These
tumors are neoplastic and can be transplanted into the ab-
domen of wild-type flies where they overgrow, invade
other tissues, and eventually kill the host (Caussinus and
Gonzalez, 2005; Gateff, 1978).
Brat and Prospero Regulate Stem Cell Self-Renewal
Asymmetric cell division has been studied in the Drosoph-
ila central and peripheral nervous systems. In the periph-
eral nervous system, the determinants Numb and Neural-
ized segregate into one of the two daughter cells, and in
their absence, this cell is transformed into its sister cell
(Le Borgne and Schweisguth, 2003; Rhyu et al., 1994). In
the embryonic central nervous system, Prospero acts as
a segregating determinant, but in prospero mutants,
many GMCs are still correctly specified. Our data suggest
that this is because Prospero acts partially redundant with
Brat. In embryos double mutant for prospero and brat,
most GMCs expressing the marker Eve are missing and
neuronal differentiation in the embryonic CNS is greatly
impaired. These observations suggest that Brat and Pros-
pero act together to specify GMC fate in Drosophila em-
bryos (Figure 7C).
Although cell-cycle markers are expressed longer and
stronger in prospero (Li and Vaessin, 2000) and brat, pros-
peromutant (data not shown) embryos, uncontrolled over-
proliferation has not been described in Drosophila em-
bryos so far. In larvae, however, both brat and prospero
mutant neuroblasts can initiate tumor formation. We pro-
pose that this difference is due to distinct mechanisms
of cell growth during the two stages. During embryogene-
sis, cell number increases dramatically but the total vol-
ume of the embryo remains constant. Embryonic neuro-
blasts therefore shrink with each division and they might
exit the cell cycle simply because they become too small.
Support for thismodel comes frommutations affecting cell
size asymmetry during neuroblast divisions, like Gb13F
(Fuse et al., 2003) or Ric-8 (Hampoelz et al., 2005): in these
mutants, GMCs are larger, neuroblasts shrink faster and—
as a consequence—divide less often. In larval neuro-
blasts, the situation is quite different. Several results indi-
cate that larval neuroblasts grow significantly while cell
growth is inhibited in GMCs. First, the total volume of
clones generated from individual neuroblasts is several
times more than the initial volume of the neuroblast (see
for example Figure 4C). Second, the size of ‘‘old’’ and
‘‘young’’ (earlier and more recently generated) GMCs is
approximately the same, indicating that GMCs do not
grow significantly during clone formation. Third, larvalCell 124, 1241–1253, March 24, 2006 ª2006 Elsevier Inc. 1249
Figure 7. Prospero Acts as a Tumor Suppressor in Larval Brains
(A andB) Single neuroblast pros17 clonesmarked by the expression of CD8-GFP show expression ofMiranda (A0) andWorniu (B0 0) and downregulation
of Brat (B0) in daughter cells. Scale bars are 10 mm.
(C) Model for the function of Brat and Prospero in embryonic and larval brain neuroblasts.neuroblasts do not become progressively smaller during
development indicating that the loss of cytoplasm from
each division must be compensated for by growth. Taken
together, these results suggest that larval neuroblasts
might be more appropriate as a model for the control of
self-renewal in stem cells.
Our experiments show that the restriction of cell growth
in the GMC requires the genes lgl, brat, and prospero
(Figure 7C). While lgl seems to be required indirectly due
to its role in asymmetric protein segregation, Prospero
and Brat act in the GMC to regulate several important
events: They repress neuroblast fate, inhibit cell-cycle
progression, and prevent cell growth. Prospero is a home-
odomain transcription factor, and the cell-cycle genes
Cyclin A, Cyclin E, and Dacapo (the fly homolog of the
CDK inhibitor p21) were shown to be among its transcrip-
tional targets (Li and Vaessin, 2000; Liu et al., 2002). Sim-
ilar to Drosophila Prospero, its vertebrate homolog Prox-1
has been shown to regulate cell-cycle genes, and loss of
prox-1 leads to increased proliferation of retinal progenitor
cells (Dyer et al., 2003).1250 Cell 124, 1241–1253, March 24, 2006 ª2006 Elsevier IncFor Brat, two different functions have been described:
First, it acts as a translational regulator of the gap-gene
hunchback (Sonoda and Wharton, 2001). Hunchback is
expressed in the embryonic nervous system but is not
present in wild-type or brat mutant larval neuroblasts
(data not shown) and is unlikely to be relevant for the
growth regulatory activity of Brat. More likely, Brat acts
through its well-described inhibitory activity on ribosomal
RNA synthesis. Cells mutant for brat or its C. elegans ho-
molog ncl-1 have larger nucleoli, more ribosomal RNA,
and higher rates of protein synthesis, and these activities
have been made responsible for the cell size increase that
is observed in C. elegans and Drosophila bratmutant cells
(Frank et al., 2002; Frank and Roth, 1998). Our data sug-
gest that this second function of Brat is also linked to post-
transcriptional gene regulation. We propose that Brat
downregulates dMyc in one of the two daughter cells
and thereby inhibits protein synthesis and cell growth.
Whether Brat controls dMyc translation, protein stability,
or RNA stability is unclear. Interestingly, the C. elegans
Brat homolog ncl-1 has been identified as one of the.
genes required for RNAi (Kim et al., 2005). Since the mi-
croRNA pathway was shown to be involved in regulation
of Drosophila stem cell proliferation (Hatfield et al.,
2005), differential regulation of this pathway in neuroblasts
and GMCs by Brat could provide another explanation for
its mutant phenotype.
Brat Homologs and Cancer Stem Cells
Brat is part of a protein family that is characterized by a C-
terminal NHL domain, several zinc-finger like B boxes, and
a coiled-coil region. While the vertebrate members of this
family (TRIM-2, TRIM-3, and TRIM-32) (Arama et al., 2000)
are not well characterized, the mutant phenotype of the
two other Drosophila members (Dappled and Mei-P26)
suggests a common function as tumor suppressors. Mu-
tations in dappled cause melanomic tumors of the fat
body (Rodriguez et al., 1996), and mei-P26 mutations
lead to ovarian tumors (Page et al., 2000). While dappled
tumors have not been well characterized, the mei-P26
phenotype has been attributed to overproliferation of un-
differentiated germ cells. It is similar to—and genetically
interacts with—bag of marbles (Page et al., 2000), a
well-characterized repressor of proliferation in the daugh-
ter cells of germline stem cells (McKearin and Ohlstein,
1995). Thus, it is conceivable that proliferation control in
stem cells is a common activity of NHL domain proteins.
Recent evidence suggests that some human brain tu-
mors contain stem cell-like neural progenitors that are re-
sponsible for tumor formation (Galli et al., 2004; Singh
et al., 2003, 2004). Together with the identification of
stem cell-like subpopulations in leukaemia, multiple mye-
loma, and breast cancer, this has led to the so-called can-
cer stem cell hypothesis which proposes that only a small
population of cells in a tumor have the ability to proliferate
and self-renew (Al-Hajj and Clarke, 2004). This discovery
suggests mechanisms for tumorigenesis other than the
simple loss of proliferation control, in particular dedifferen-
tiation of cells into additional stem cells and symmetric di-
vision of stem cells. Animal models for tumor stem cells
are essential for developing new therapeutic approaches
that target these mechanisms. Although Drosophila can
only mimic some aspects of tumorigenesis, it might con-
tribute to the identification of the molecular pathways op-
erating in tumor stem cells. Human Lgl has already been
implicated in tumor progression (Grifoni et al., 2004; Schi-
manski et al., 2005), and the characterization of Brat ho-




brat mutants have been described previously (Luschnig et al., 2004).
Mutations were identified by sequencing homozygous mutant geno-
mic DNA: in brat2L-150-11-2 (called brat150) and brat2L-192-9-1 (called
brat192), Gln (926) and Gln (417) are changed into stop codons, respec-
tively. Other fly strains aremiraL44 (Matsuzaki et al., 1998); pros17 (Doe
et al., 1991); FRT82B, pros17 (from V. Rodrigues); FRT40A, lgl1 and
FRT40A, lgl4 (from F. Matsuzaki); FRT40A, dPTEN1 (Goberdhanet al., 1999); UAS-mycDp110 and UAS-mycDp110D954A (Leevers
et al., 1996); UAS-dMyc (from B. Edgar); UAS-CD8-GFP (Bloomington
stock center); UAS-aPKCDN (Betschinger et al., 2003); MARCM
stocks using C155Gal4 (Lee and Luo, 1999); yw, hsFlp; Act-FRT-y-
FRT-Gal4, UAS-lacZ(nls) for clonal overexpression. Transgenes were
expressed in embryos using maternalGal4 (from D. St. Johnston)
and in brains using 1407-Gal4 (Luo et al., 1994) inserted in the inscute-
able promotor. Maternal zygotic null mutants were generated using
ovoD and hsFlp.
Constructs and Antibodies
Miranda fragments and Brat and CG17593 coding sequences were
PCR-amplified with primers containing attB recombination sites and
recombined into pDONR221 (Invitrogen). TAP-tagged constructs
were generated by recombining pDONR221-constructs into a hs-
pCasper destination vector containing the TAP tag (Rigaut et al.,
1999) and attR recombination sites. GFP-fusion constructs were gen-
erated by recombining inserts into a pUAST-vector with a N-terminal
EGFP and attR recombination sites. Transgenic Mira RNAi was gener-
ated by cloning inverted repeats (nucleotides 940-1209) of theMiranda
coding sequence into pMF3 (G. Dietzl and B. Dickson, personal com-
munication).
Brat antibodies (affinity-purified, 1:200) were raised in rabbits
against a peptide containing amino acids 4–20 (CSPTPSLDSMR
GGANSIE). Miranda antibodies (affinity-purified, 1:100) were gener-
ated in rabbits using a peptide containing amino acids 96–118
(CSLPQRLRFRPTPSHTDTATGSGS). Other antibodies are mouse
anti-Pros (1:10, MR1A, Developmental Studies Hybridoma Bank), rab-
bit anti-Eve (1:2000, from M. Frasch), mouse anti-CNS axons (1:10,
BP102, Developmental Studies Hybridoma Bank), rabbit anti-Zfh1
(1:500, from Z. Lai), mouse anti-GFP (1:100, Roche), rabbit anti-GFP
(1:100, Abcam), rabbit anti-Mira (Shen et al., 1997), rat anti-Brat
(Sonoda and Wharton, 2001), mouse anti-Wor (Cai et al., 2001), rat
anti-CycE (1:500, from H. Richardson), mouse anti-CycE (1:10, from
H. Richardson), mouse anti-BrdU (1:5, BD Pharmigen), mouse anti-
phosphoH3 (1:1000, Cell Signaling Technology), rat anti-CD8 (1:100,
Caltag Laboratories), rabbit anti-dFOXO (Puig et al., 2003), chicken
anti-lacZ (1:1000, Abcam), mouse anti-c-myc (1:100, Santa Cruz Bio-
technology), mouse anti-dMyc (1:5, from B. Edgar), and mouse anti-
Fibrillarin (1:10, Abcam).
Immunohistochemistry
Immunofluorescence experiments in embryos were carried out essen-
tially as described (Betschinger et al., 2003). For larval brain stainings,
larvae were dissected in PBS, and brains with attached ventral nerve
cords were fixed for 20 min in 5% PFA; 0.2% Triton X-100 and pro-
cessed like embryos. For hsFlp experiments, larvae were heat-
shocked for 1 hr at 37ºC on two successive days and dissected 3 or
4 days later. BrdU incorporation was essentially performed as
described (Ceron et al., 2001). Briefly, larvae were dissected in
Schneider’s medium (Gibco) and brains were incubated for 30 min
with 37.5 mg BrdU/ml (BD Pharmigen) in Schneider’s medium. Brains
were fixed for 3 min in modified Carnoy’s fixative (58% ethanol; 30%
chloroform; 10% acetic acid; 2% formaldehyde) and treated with
75% EtOH for 30 min and 2N HCl for 40 min. After extensive washing,
brains were processed by standard immunochemistry protocols.
Biochemistry and Mass Spectrometry
TAP-tagged constructs were expressed in 4–7 hr embryos by a 30 min
heat shock at 37ºC. After 45min recovery at room temperature, embry-
onic extracts were prepared in lysis buffer (20 mM HEPES pH 8.0;
150 mM NaCl; 0.5% NP40; 10% glycerol; 0.5 mM EDTA; 1 mM DTT;
1 mM PMSF; protease inhibitor cocktail [Roche]) and centrifuged for
15 min at 14000 rpm. The supernatant was incubated with chemically
crosslinked (see below) IgG-Sepharose for 1 hr. After extensive wash-
ing with lysis buffer, beads were equilibrated in lysis buffer withoutCell 124, 1241–1253, March 24, 2006 ª2006 Elsevier Inc. 1251
detergent. Beads were eluted three times with 1 bed volume of 50 mM
HCl and eluates were pooled.
To avoid elution of the IgG light chain by HCl treatment, light chains
were crosslinked to heavy chains. For this, IgG-Sepharose (Amersham
Biosciences) was equilibrated in 0.2 M sodium borate pH 9.0 and
treated with 40 mM dimethyl pimelimidate (Sigma) for 1 hr. Excess
binding sites were blocked with 1 M Tris pH 8.0 and beads were
pre-eluted with 50 mM HCl.
Eluates were neutralized with Tris pH 8.0, reduced with DTT,
carboxymethylated using iodoacetamide, and digested with trypsin
overnight. After acidifying with TFA, solutions were separated by
nano HPLC chromatography (LC-Packings, Netherland) on a PepMap
C 18 column. The eluate of the column was applied online to a LTQ
linear ion trap mass spectrometer (Thermo Finnigan). Mass data on
all peptides and their fragmentation patterns were analyzed using
MASCOT software (Matrix Science).
Identified proteins with a MASCOT probability score above 40 ob-
tained in two independent experiments were related in a database
(Access, Microsoft) and scored for proteins present in the Miranda
cargo domain but in none of the control construct purifications (scores
are: Brat, 704/418.6; Prospero, 182/264.6; Staufen, 113.4/73.7;
CG17593, 67.7/100.5).
Supplemental Data
Supplemental data include one figure and can be foundwith this article
online at http://www.cell.com/cgi/content/full/124/6/1241/DC1/.
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